Peripheral VA-ECMO #2: Femoral Perfusion Physiology

1. Core concept

Femoral veno-arterial extracorporeal membrane oxygenation (VA-ECMO) returns oxygenated blood into the femoral artery and thereby generates retrograde aortic flow. This is the defining hemodynamic feature of peripheral femoral support. Instead of physiologic antegrade systemic perfusion from the left ventricle (LV), oxygenated circuit flow ascends from the descending aorta toward the arch, where it interacts with any residual native LV ejection [1].

As a result, systemic oxygen delivery during femoral VA-ECMO is not determined by pump flow alone. It is determined by the continuously changing relationship among ECMO flow, native cardiac output, pulmonary gas exchange, and vascular resistance. This dynamic interaction explains why blood flow distribution to the brain, coronaries, abdominal organs, and lower extremities can shift significantly even when the circuit settings appear stable [1].

2. Retrograde flow and the hemodynamic competition zone

In a patient with minimal native output, most systemic perfusion is supplied by the ECMO circuit. Oxygenated blood enters the femoral artery, flows retrogradely through the iliac system and descending thoracic aorta, and then reaches the arch vessels. In that state, upper- and lower-body perfusion are predominantly ECMO-derived.

Once myocardial recovery begins, however, the LV may resume antegrade ejection across the aortic valve. At that point, the aorta becomes a competition field between two opposing streams:

1. Retrograde ECMO flow from the femoral arterial cannula
2. Antegrade native LV ejection from the aortic root

The interface between these two streams is the watershed or transitional zone. Its location is not fixed. It migrates according to changes in ECMO flow, LV recovery, systemic vascular tone, and pulmonary function. This moving mixing point is one of the most important physiologic concepts in femoral VA-ECMO, because it determines which organs are perfused primarily by circuit blood and which are perfused primarily by native ejection [1,7].

3. Why the watershed zone matters clinically

The watershed zone becomes especially important when pulmonary recovery lags behind myocardial recovery. In that setting, the LV may eject blood that is hemodynamically useful but still poorly oxygenated. If native ejection is directed into the proximal aorta while ECMO continues to perfuse the distal aorta retrogradely, the patient may develop differential hypoxia, also called Harlequin syndrome or North–South syndrome [7].

This means that the brain, coronary arteries, and right upper extremity may receive predominantly desaturated native output, while the lower body continues to receive well-oxygenated ECMO blood. The circulation may therefore appear globally acceptable if one looks only at femoral or lower-body values, while the organs most vulnerable to hypoxemia—the myocardium and brain—are actually underperfused with inadequately oxygenated blood [1,7].

This is why femoral VA-ECMO should always be interpreted as a regional perfusion problem, not simply a total-flow problem.

4. Differential hypoxia: practical bedside interpretation

A practical way to frame this physiology is as follows:

• ECMO restores systemic flow from below
• The native LV restores ejection from above
• If the lungs remain severely impaired, the recovering LV may eject the wrong blood to the most critical organs

Thus, the relevant question is not simply whether pulsatility has returned, but what oxygen content the LV is ejecting and where that blood is going [7].

Typical warning signs include:

• acceptable or even reassuring lower-body oxygen saturation,
• declining right radial or right brachial saturation,
• worsening cerebral oximetry,
• persistent pulmonary edema or severe lung dysfunction despite partial cardiac recovery,
• increasing concern that the coronary and cerebral circulations are no longer predominantly ECMO-supported.

Accordingly, right-arm arterial monitoring is essential in femoral VA-ECMO. Right radial arterial blood gas analysis is often the most useful bedside method for detecting evolving upper-body hypoxemia [7].

5. Femoral arterial return and LV afterload

A second major physiologic consequence of femoral VA-ECMO is increased LV afterload. Retrograde flow raises aortic pressure and therefore increases the resistance against which the LV must eject. In a severely impaired ventricle, this can reduce aortic valve opening, increase LV end-diastolic pressure, promote pulmonary venous congestion, and lead to progressive LV distension [1,6].

This point is clinically crucial. Femoral VA-ECMO can restore systemic perfusion while simultaneously worsening the mechanical environment of the failing LV. If the aortic valve opens poorly, pulsatility diminishes, pulmonary edema worsens, or the LV appears distended on echocardiography, the team should actively consider whether LV unloading is required [1,6].

Depending on the clinical context, unloading may involve:

• optimization of preload and afterload,
• adjustment of inotropes,
• atrial septostomy or left atrial decompression,
• direct surgical venting,
• or combined mechanical support strategies such as ECMO with an Impella-based unloading approach.

The principle is not that every patient requires invasive decompression, but that LV distension should be anticipated, monitored, and treated early when present [6].

6. Distal limb perfusion: a major vascular complication

Femoral arterial cannulation can also compromise antegrade perfusion to the cannulated extremity. For that reason, distal limb ischemia remains one of the most important complications of peripheral VA-ECMO [2-5].

The mechanism is multifactorial. Direct arterial obstruction by the cannula is often central, but limb ischemia may also be worsened by loss of pulsatile flow, vasoconstriction related to shock or vasoactive drugs, thromboembolism, vessel injury, and impaired venous drainage with secondary tissue congestion [3-5]. Reported vascular complication rates vary across series, but clinically significant limb ischemia remains common enough that it should be assumed to be an ongoing risk rather than an unusual event [2-5].

Risk is not evenly distributed. Observational data suggest that younger patients and those with diabetes, pulmonary disease, or peripheral arterial disease may be particularly vulnerable [3]. This reinforces the need to individualize cannula size, access strategy, and surveillance intensity.

7. Contemporary approach to prevention and monitoring of limb ischemia

Current practice has moved away from a purely reactive strategy. There is increasing emphasis on early or prophylactic distal perfusion support, especially when vessel caliber is small, perfusion is marginal, or the cannulation is expected to be prolonged [2,4,5].

Monitoring should be systematic and repeated:

A. Clinical examination

• limb color,
• temperature,
• capillary refill,
• motor and sensory status when assessable,
• compartment tension.

B. Bedside perfusion assessment

• distal Doppler signals,
• duplex ultrasound when concern arises,
• serial lactate trends in context.

C. Tissue oxygenation monitoring

• near-infrared spectroscopy (NIRS), when available, can help identify evolving malperfusion earlier than gross clinical changes alone [4,5].

The distal perfusion catheter should therefore be viewed not as a minor adjunct, but as a core limb-preservation strategy in appropriately selected patients. Recent literature also highlights evolving alternatives and refinements, including end-to-side grafting, retrograde distal perfusion techniques, and strategies that address venous congestion as a contributor to limb compromise [5].

8. Monitoring priorities in daily femoral VA-ECMO management

Because the circulation is regionally heterogeneous, monitoring should be equally nuanced.

1) Upper-body oxygenation

• right radial arterial blood gas,
• right upper-extremity pulse oximetry,
• cerebral NIRS when available.

These are essential for recognition of differential hypoxia [7].

2) Native cardiac contribution

• arterial pulsatility,
• echocardiographic assessment of LV size and contractility,
• aortic valve opening,
• evidence of spontaneous echo contrast or stasis.

These help define how much native output is competing with ECMO flow and whether afterload-related LV distension is developing [1,6].

3) Pulmonary recovery

• radiographic lung status,
• ventilator requirements,
• gas exchange trends.

These determine the oxygen content of pulmonary venous return and therefore of native LV ejection [7].

4) Distal extremity perfusion

• repeated vascular examination,
• Doppler/NIRS/ultrasound as needed,
• low threshold for intervention if perfusion worsens.

9. Management principles when differential hypoxia occurs

When Harlequin physiology develops, management should focus on restoring adequate oxygen delivery to the proximal circulation while preserving systemic support [7].

Common strategies include:

1. Improve pulmonary oxygenation

Optimize ventilation, recruitment, airway clearance, and lung-directed therapy.

2. Adjust ECMO flow and overall hemodynamics

In some patients, increasing ECMO flow may move the watershed proximally, although this is not always sufficient.

3. Reassess native ejection quality, not just quantity

A stronger LV is not necessarily beneficial if it is ejecting poorly oxygenated blood.

4. Consider alternative support configurations when needed

If upper-body hypoxemia remains unresolved, a different cannulation configuration or an upper-body return strategy may be necessary [7].

The key principle is that successful management of femoral VA-ECMO requires balancing flow, oxygen content, and ventricular loading conditions at the same time.

10. Clinical summary

Femoral VA-ECMO is fast, versatile, and often lifesaving, but it creates a circulation that is inherently nonphysiologic. Its major features are:

• retrograde aortic perfusion
• competition between ECMO flow and native LV ejection
• a mobile watershed zone
• the risk of differential upper-body hypoxemia
• increased LV afterload with possible distension
• and distal limb malperfusion related to femoral arterial cannulation [1-7].

For that reason, femoral VA-ECMO should not be managed as a static pump setting. It should be managed as a dynamic, regionally variable circulation. At the bedside, three questions remain central:

1. Where is the blood going?
2. How well oxygenated is it?
3. What cost is being imposed on the LV and the cannulated limb?

That framework captures the essential physiology of femoral ECMO perfusion and provides the safest basis for daily clinical decision-making.

References

[1] Rao P, Khalpey Z, Smith R, Burkhoff D, Kociol RD. Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest. Circ Heart Fail. 2018;11(9):e004905.

[2] Bonicolini E, Martucci G, Simons J, Raffa GM, Spina C, Lo Coco V, Arcadipane A, Pilato M, Lorusso R. Limb ischemia in peripheral veno-arterial extracorporeal membrane oxygenation: a narrative review of incidence, prevention, monitoring, and treatment. Crit Care. 2019;23(1):266.

[3] Yau P, Xia Y, Shariff S, Jakobleff WA, Forest S, Lipsitz EC, Scher LA, Garg K. Factors Associated with Ipsilateral Limb Ischemia in Patients Undergoing Femoral Cannulation Extracorporeal Membrane Oxygenation. Ann Vasc Surg. 2019;54:60-65.

[4] Hart JP, Davies MG. Vascular Complications in Extracorporeal Membrane Oxygenation-A Narrative Review. J Clin Med. 2024;13(17):5170.

[5] Simons J, Mees BME, MacLaren G, Fraser JF, Zaaqoq AM, Cho SM, Patel BM, Brodie D, Bělohlávek J, Belliato M, Jung JS, Salazar L, Meani P, Mariani S, Di Mauro M, Yannopoulos D, Broman LM, Chen YS, Riera J, van Mook WNKA, Lorusso R. Evolution of distal limb perfusion management in adult peripheral venoarterial extracorporeal membrane oxygenation with femoral artery cannulation. Perfusion. 2024;39(1_suppl):23S-38S.

[6] Russo JJ, Aleksova N, Pitcher I, Couture E, Parlow S, Faraz M, Visintini S, Simard T, Di Santo P, Mathew R, So DY, Takeda K, Garan AR, Karmpaliotis D, Takayama H, Kirtane AJ, Hibbert B. Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock. J Am Coll Cardiol. 2019;73(6):654-662.

[7] Torre DE, Pirri C. Harlequin Syndrome in Venoarterial ECMO and ECPELLA: When ECMO and Native or Impella Circulations Collide - A Comprehensive Review. Rev Cardiovasc Med. 2025;26(8):39992.